Document Detail

Pregnancy outcome after gestational exposure to erythromycin - a population-based register study from Norway.
MedLine Citation:
PMID:  22463376     Owner:  NLM     Status:  MEDLINE    
AIMS: Erythromycin is a macrolide antibiotic indicated for respiratory tract infections, genital chlamydia and skin infections. It has recently been suggested that erythromycin use in the first trimester of pregnancy can increase the risk of congenital cardiovascular malformations. This study aimed to determine whether erythromycin exposure in the first trimester is associated with cardiovascular or other malformations.
METHODS: We studied 180 120 women in Norway who were pregnant during 2004-2007. Data on all live births stillbirths and induced abortions after 12 gestational weeks from The Medical Birth Registry of Norway (MBRN) were linked to information from the Norwegian prescription database (NorPD). We compared the pregnancy outcomes of women who had taken erythromycin (n= 1786, 1.0%), penicillin V (n= 4921, 2.7%) or amoxicillin (n= 1599, 0.9%) in their first trimester with outcomes of women who had not taken any systemic antibiotics (n= 163 653, 90.9%) during this period.
RESULTS: The risk of cardiovascular malformations was not significantly different with or without exposure to erythromycin in the first trimester (adjusted OR = 1.2 [95% CI 0.8, 1.8]) or in the most vulnerable period of heart formation (adjusted OR = 1.6 [95% CI 0.9-3.0]). Sub-analyses showed that the risk for any specific malformations was not increased with erythromycin, macrolides, penicillin V or amoxicillin compared with no antibiotic use in first trimester.
CONCLUSIONS: This large, population-based register study did not find that exposure to erythromycin or macrolides in the first trimester of pregnancy was associated with fetal cardiovascular or other malformations. These results suggest that the risk of erythromycin use during early pregnancy, if any, is low.
Maria Romøren; Morten Lindbæk; Hedvig Nordeng
Related Documents :
24421066 - Obsessive-compulsive disorder and female reproductive cycle events: results from the oc...
3136246 - In vivo permeability of the human placenta to inulin and mannitol.
22444956 - Effects of binge drinking on infant growth and development in an inuit sample.
7939586 - Cobalt excretion in urine: results of a study on workers producing diamond grinding too...
9918816 - Serum leptin levels do not rise during pregnancy in age-matched rats.
15920896 - Antibiotic therapy in pregnancy and lactation.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of clinical pharmacology     Volume:  74     ISSN:  1365-2125     ISO Abbreviation:  Br J Clin Pharmacol     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-13     Completed Date:  2013-04-16     Revised Date:  2013-12-06    
Medline Journal Info:
Nlm Unique ID:  7503323     Medline TA:  Br J Clin Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  1053-62     Citation Subset:  IM    
Copyright Information:
© 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abnormalities, Drug-Induced / etiology*
Anti-Bacterial Agents / adverse effects*
Case-Control Studies
Erythromycin / adverse effects*
Heart Defects, Congenital / chemically induced*
Logistic Models
Middle Aged
Pregnancy Outcome
Pregnancy Trimester, First / drug effects
Prenatal Exposure Delayed Effects / chemically induced*
Young Adult
Reg. No./Substance:
0/Anti-Bacterial Agents; 63937KV33D/Erythromycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Preliminary methylation analysis of prothymosin ? genomic sequences.
Next Document:  Scaling and mechanics of the felid calcaneus: geometric similarity without differential allometric s...